During the periovulatory period, the profile of fibroblast growth factor 2 (FGF2) coincides with elevated prostaglandin E2 (PGE2) levels. We investigated whether PGE2 can directly stimulate FGF2 production in bovine granulosa cells and, if so, which prostaglandin E2 receptor (PTGER) type and signaling cascades are involved. PGE2 temporally stimulated FGF2. Accordingly, endoperoxidesynthase2-silenced cells, exhibiting low endogenous PGE2 levels, had reduced FGF2. Furthermore, elevation of viable granulosa cell numbers by PGE2 was abolished with FGF2 receptor 1 inhibitor, suggesting that FGF2 mediates this action of PGE2. Epiregulin (EREG), a known PGE2-inducible gene, was studied alongside FGF2. PTGER2 agonist elevated cAMP as well as FGF2 and EREG levels. However, a marked difference between cAMP-induced downstream signaling was observed for FGF2 and EREG. Whereas FGF2 upregulated by PGE2, PTGER2 agonist, or forskolin was unaffected by the protein kinase A (PKA) inhibitor H89, EREG was significantly inhibited. FGF2 was dosedependently stimulated by the exchange protein directly activated by cAMP (EPAC) activator; a similar induction was observed for EREG. However, forskolin-stimulated FGF2, but not EREG, was inhibited in EPAC1-silenced cells. These findings ascribe a novel autocrine role for PGE2, namely, elevating FGF2 production in granulosa cells. This study also reveals that cAMP-activated EPAC1, rather than PKA, mediates the effect of PGE2/PTGER2 on the expression of FGF2. Stimulation of EREG by PGE2 is also mediated by PTGER2 but, in contrast to FGF2, EREG was found to be PKA sensitive. PGE2-stimulated FGF2 can act to maintain granulosa cell survival; it can also act on ovarian endothelial cells to promote angiogenesis. (Endocrinology 159: 3482-3491, 2018) 
ndoperoxide synthase 2 (PTGS2) is the rate-limiting enzyme in the conversion of arachidonic acid into prostaglandins, including prostaglandin E2 (PGE2). Knockout of PTGS2 and PTGS inhibitors results in failed ovulation but with normal luteinization and trapped oocytes in the corpus luteum (CL) (1) (2) (3) (4) (5) . These studies proved that PGE2 plays a key role in ovulation. PTGS2 is abruptly induced in response to LH in the granulosa cells of follicles approaching ovulation (6) (7) (8) . Studies have shown that PGE2 increases progesterone production in various species (9) (10) (11) (12) . PGE2 is also implicated in ovarian angiogenesis (13, 14) . Rat and primate follicles treated with PTGS2 inhibitors had a suppressed vasculature in newly formed rat CL (14) and ovulating monkey follicle (13) , respectively, this suppression was eliminated by replenishing PGE2.
PGE2 binds its four cognate receptors (PTGERs) (15, 16) . The expression of PTGERs has been reported in periovulatory follicles of several species (17) . PTGER2 knockout mice exhibited phenotypes similar to PTGS2 knockout mice (18, 19) , suggesting that this receptor type subserves PGE2 actions during ovulation. PTGERs belong to the G protein-coupled receptor family (17) . They are coupled to different G proteins and regulate distinct downstream signaling pathways (15) . PTGER2 and PTGER4 are coupled to G a S, which activates adenylyl cyclase and elevates intracellular cAMP levels (15, 20) .
Classically, cAMP actions are mediated by cAMPdependent protein kinase A (PKA). Other cAMP effectors were also described (21, 22) . Exchange proteins directly activated by cAMP (EPACs) have evolutionarily conserved cAMP binding domains and guanine nucleotide exchange factor domains (22, 23) . The two isoforms of EPAC, namely, EPAC1 and EPAC2, are encoded by the rap guanine exchange factor (RAPGEF) 3 and RAPGEF4 genes, respectively (24) . EPAC proteins were implicated in various processes, such as insulin secretion from pancreatic b cells (25) and human chorionic gonadotropin (hCG) activates Epac-Erk1/2 signaling in human endometrial stromal cells (26) .
Interestingly, the profile of fibroblast growth factor 2 (FGF2), a well-known luteal proangiogenic factor (27) (28) (29) , coincides with elevated PGE2 levels during the periovulatory period (30) (31) (32) . Furthermore, both FGF2 and PGE2 are synthesized by granulosa cells in response to LH (27, 30) . This temporal and spatial association could enable mutual regulation of these two factors. Therefore, we investigated whether PGE2 can directly stimulate FGF2 production in bovine granulosa cells and, if so, which PTGER type and signaling cascades are involved in such an action. To better understand the signaling pathways triggered by PGE2, epiregulin (EREG), a known PGE2-dependent gene in granulosa cells (33) (34) (35) , was studied along with FGF2.
Materials and Methods
Unless otherwise stated, all biochemical reagents were obtained from Sigma-Aldrich (St. Louis, MO) and cell culture materials were from Biological Industries (Kibbutz Beit Haemek, Israel).
Isolation and culture of granulosa cells
Bovine ovaries were collected at a local abattoir, as previously described (36) . Ovaries containing a large follicle (1.2-to 1.5-cm diameter) but without an active CL in the ipsilateral or the contralateral ovary were chosen. Bovine granulosa cells were enzymatically dispersed from these large follicles by using a combination of collagenase I (125 U/mL), hyaluronidase III (36 U/mL), and deoxyribonuclease I (11 U/mL) in DMEM/ nutrient mixture F-12 (F-12) containing 2 mM L-glutamine and 100 mg/mL penicillin/streptomycin. Only large follicles containing $4 million viable cells were used. Granulosa cells were cultured overnight in medium containing 3% fetal calf serum (FCS). They were seeded in either six-well dishes (500,000 cells per well) or 12-well dishes (250 ,000 cells per well) and cultured overnight in DMEM/F-12 medium containing 3% FCS.
The following compounds were tested: forskolin (1 or 10 mmol/L); PGE2 (1 mmol/L; Cayman Chemical, Ann Arbor, MI); or the following PGE2 receptor agonists (10 mmol/L; Cayman Chemical): 17-phenyl trinor prostaglandin E2 (a PTGER1 agonist), butaprost (a PTGER2 agonist), sulprostone (a PTGER3 agonist), and prostaglandin E1 alcohol (a PTGER4 agonist); H89 dihydrochloride (5 mmol/L; Biaffin, Kassel, Germany); 8-(4-chlorophenylthio)-2'-O-Me-cAMP-AM (an EPAC activator; Biaffin) for designated time points as indicated in the text.
Transfection of cells
For transfection experiments, bovine granulosa cells were trypsinized with 0.05% trypsin and 0.02% EDTA solution immediately after isolation from follicles. Trypsinized granulosa cells were seeded and cultured overnight in 3% FCS. Then cells were transfected using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol in 1% FCS. Cells were transfected with 50 nmol/L small interfering RNA (siRNA; Genecust, Luxembourg; or Sigma-Aldrich) of either constructs targeting PTGS2 (35), RAPGEF3, RAPGEF4, or with scrambled siRNA (the negative control). The siRNA sequences used for gene silencing are presented in Table 1 . siRNAs were designed using the following tools available online: sidirect2 (sidirect2.rnai.jp/) and i-score designer (med.nagoya-u.ac.jp/ neurogenetics/i_Score/i_score). A day after transfection, cells were treated with forskolin (1 or 10 mmol/L). At 48 hours after transfection, cells and culture media were harvested. 
Determination of viable cell numbers
Granulosa cells were seeded in 96-well dishes (25,000 cells per well) and cultured overnight in DMEM/F-12 medium containing 3% FCS. The next day, the cells were preincubated with or without PD173074 (100 nmol/L; FGF receptor1 inhibitor; Cayman Chemical) for 1 hour in 1% FCS medium. Then, cells were incubated for 48 hours with PGE2 (1 mmol/L) or FGF2 (10 ng/mL) in the presence or absence of PD173074 (100 nmol/L). Cell numbers were estimated, as previously described (29, 37) , using the XTT kit, which measures the reduction of a tetrazolium component by the number of mitochondria of viable cells. On the day of measurement, XTT was added according to the manufacturer's instructions. Plates were incubated at 37°C for 3 hours and the absorbance was read at 450 nm (reference absorbance, 630 nm).
RNA extraction and real-time PCR
Total RNA was isolated using Tri-Reagent (Molecular Research Center) according to the manufacturer's instructions. Total RNA (1 mg) was reverse transcribed. Real-time PCR was performed using the LightCycler 96 system (Roche Diagnostics, Indianapolis, IN) with LightCycler 480 SYBR Green I Master (Roche Diagnostics). The glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene was the reference gene. The primer sequences used are listed in Table 2 . Primers were designed using Oligo Primer analysis software (Molecular Biology Insights, Colorado Springs, CO), based on the available bovine sequences, and spanned an intron to prevent amplification of genomic DNA. Dissociation curve analysis was performed after each real-time experiment to confirm the presence of only one product and the absence of the formation of primer dimers. The threshold cycle (Ct) number was used to quantify the relative abundance of the gene; arbitrary units were calculated as 2 2DCt =2 2 (Ct target gene 2 Ct housekeeping gene) .
Western blot analyses
FGF2 protein was extracted from granulosa cells by adding sample buffer (twice). These extracts contain cell lysate and matrices deposited by the cells. Because FGF2 protein is bound to heparan sulfate proteoglycans in these two compartments Bovine granulosa cells were incubated with or without forskolin (10 mmol/L) for the times indicated. The results represent the mean 6 SEM from three independent experiments. Asterisks indicate significant differences from their respective basal levels without forskolin: *P , 0.05; **P , 0.01. Basal levels at 6 h were designated as 1.
(38, 39), these extracts represent total FGF2 levels produced by the granulosa cells. Proteins were separated by 7.5% to 12.0% SDS-PAGE and subsequently transferred to nitrocellulose membranes, as previously reported (37, 40 
Determination of cAMP production
Granulosa cells were preincubated for 10 minutes in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (100 nmol/L), which was also present during the entire incubation period. Incubation was carried out for 30 and 60 minutes with basal (1% FCS) medium containing PGE2 (1 mmol/L) or PTGER2 agonist (10 mmol/L). At the end of incubation period, cell culture media were collected, boiled for 4 minutes at 100°C, and frozen until assayed for cAMP by the cAMP enzyme immunoassay kit (Cayman Chemical) according to the manufacturer's instruction. cAMP was determined after acetylation, using cAMP-acetylcholinesterase conjugate as a tracer. The standard curve ranged from 0.078 to 5 pmol/mL. Cross reactivity of the assay with acetylated cAMP was 100% and ,0.01% for acetylated AMP. The interand intra-assay coefficient of variation values were 9.2% and 11.4%, respectively.
PGE2 analysis
Media from the cell cultures were collected on the day of RNA isolation. Levels of PGE2 were measured by the PGE2 enzyme immunoassay kit (monoclonal; Cayman Chemical) according to the manufacturer's instructions. The standard curve ranged from 6.4 pg/mL to 1000 pg/mL. Cross-reactivity of the assay with PGE2 was 100% and 0.01% for prostaglandin F2a. The inter-and intra-assay coefficient of variation values were 15% and 7.2%, respectively.
Statistical analyses
Data are presented as mean 6 SEM; experiments were repeated at least three times. Statistical analyses were performed using Student t test or one-way ANOVA, followed by Bonferroni multiple comparison tests, when appropriate. In all analyses, a value of P , 0.05 was considered significant. Fig. 1A ). In agreement with our previous findings (35), PGE2 also upregulated EREG (12-fold increase) at 3 hours (Fig. 1B) . Amphiregulin (AREG), another epidermal growth factor (EGF)-like factor, responded to PGE2 similarly to EREG, although its levels were markedly lower than those of EREG (data not shown). At 6 hours, the fold inductions of FGF2 and EREG from control levels were similar to those observed at 3 hours. Asterisks indicate significant differences from scrambled siRNA: *P , 0.05; **P , 0.01; *** P , 0.001.
Results

PGE2 elevated
Later, PGE2-stimulated mRNA levels of both FGF2 and EREG gradually declined until 12 hours. PGE2 also elevated FGF2 protein (at 12 hours; inset Fig.  1A ). In addition, FGF2 and EREG were temporally elevated by forskolin (adenylyl cyclase activator) (Fig. 2) . To further strengthen the role of PGE2 in FGF2 induction, PTGS2 was silenced with siRNA ( Fig. 3) . PTGS2 knockdown (70% reduction of PTGS2) (35) markedly lowered PGE2 levels in culture media (Fig. 3A) . Low endogenous PGE2 levels resulted in decreased FGF2 production (42% and 72% lower mRNA and protein levels, respectively, compared with scrambled siRNA; Fig. 3B and 3C ). FGF2 is known to stimulate granulosa cell proliferation (29, 44) . We also observed here that PGE2 significantly doubled the viable granulosa cell numbers as compared with control (Fig. 4) . To determine whether PGE2 affected the viable granulosa cells via FGF2, FGFR1 inhibitor (PD173074; 100 nmol/L) was used. Indeed, as shown in Fig. 4 , PD173074 abolished the stimulatory effect of PGE2. As expected, the action of exogenous FGF2 (10 ng/mL) was also eliminated by FGFR1 inhibitor (Fig. 4) . These findings suggest that FGF2 mediates the effect of PGE2 on granulosa cell proliferation.
PTGER2 mediated PGE2-stimulated FGF2 and EREG via distinct cAMP pathways
To determine which of the four PGE receptor types stimulates FGF2 and EREG, specific receptor agonists were used. As shown in Fig. 5 , the highest stimulation of FGF2 and EREG was achieved with PTGER2 agonist (sevenfold increase after 3 hours as compared with control). At 6 hours, the induction of FGF2 and EREG by this agonist was further increased (as compared with its own control levels). FGF2 and EREG levels were also slightly but significantly elevated by the PTGER1 and PTGER4 agonists (Fig.5A and 5B) but not by the PTGER3 agonist (Fig. 5) .
To explore PGE2-mediated downstream signaling, cAMP levels were determined. As shown in Table 3 , cAMP levels were significantly elevated in culture media of granulosa cells incubated for 30 minutes with PGE2 or PTGER2 agonist (116.7 pg and 13.8 pg per 250,000 cells, respectively). cAMP levels were further elevated after 60 minutes of incubation (Table 3) . Next, to examine the involvement of classical cAMP-dependent PKA, granulosa cells were incubated with PKA inhibitor (H89; Figure 4 . Effects of PGE2 and FGF2 on the viable granulosa cell numbers. Bovine granulosa cells were preincubated for 1 h with or without PD173074 (100 nmol/L; FGF receptor 1 inhibitor). Then cells were exposed to PGE2 (1 mmol/L) or FGF2 (10 ng/mL) in the presence or absence of PD173074 for 48 h. Viable cell numbers were determined by XTT. The results represent the mean 6 SEM from four independent experiments. Data are presented as the fold change of the control (Ctrl) designated as 1. Multiple comparisons were performed by one-way ANOVA followed by Bonferroni multiple comparison tests. Different letters denote statistical difference (P , 0.05). Asterisks indicate significant differences from the respective control (Ctrl): *P , 0.05; **P , 0.01; ***P , 0.001.
mmol/L).
A clear difference between FGF2 and EREG expression was observed (Fig. 6) . FGF2 upregulated by either PGE2, PTGER2 agonist, or forskolin was unaffected by the presence of H89 (Fig. 6A) . On the other hand, a distinct inhibitory effect of H89 on EREG elevated by PGE2, PTGER2 agonist, or forskolin was observed as compared with respective treatment without H89 (50% to 65% decrease; Fig. 6B ).
We then investigated another evolutionarily conserved cAMP binding protein (i.e., EPACs). The two isoforms, EPAC1 and EPAC2, encoded by the RAPGEF3 and RAPGEF4 genes, respectively, were expressed in bovine granulosa cells, although expression of RAPGEF3 was fourfold higher than RAPGEF4 (EPAC2; data not shown). As depicted in Fig. 7A , The EPAC-selective activator 8-pCPT-AM dose-dependently increased FGF2 expression. Surprisingly, 8-pCPT-AM also upregulated EREG expression (Fig. 7B) , although the level of this induction was somewhat lower than that induced by upstream stimulants (Fig. 6) . The functional importance of the two EPAC isoforms was further examined by transfecting bovine granulosa cells with specific siRNAs targeting either RAPGEF3 or RAPGEF4. These siRNAs significantly silenced their respective RAPGEFs (50% lower than in scrambled siRNA) without interfering with the levels of the other type (Fig. 8) . Silencing RAPGEFs did not affect FGF2 and EREG levels under unstimulated conditions (controls; Fig. 9 ). Because PTGERs are not retained in trypsinized granulosa cells (in preparation for transfection; see "Materials and Methods"), forskolin was used to elevate the intracellular cAMP. A significant inhibition (35%; P = 0.02) was noted in forskolin-stimulated FGF2 by the silencing of RAPGEF3 as compared with scrambled siRNA transfected cells (Fig. 9A) . RAPGEF4 silencing did not affect FGF2 (Fig.  9A) . In contrast to FGF2, forskolinstimulated EREG levels were not reduced by silencing either RAPGEF3 or RAPGEF4 (Fig. 9B ).
Discussion
The findings reported here ascribe an autocrine role for PGE2, specifically, elevating FGF2 production in bovine granulosa cells. This study also reveals that cAMP-activated EPAC1 mediates the effect of PGE2/PTGER2 on the expression of FGF2 (Fig. 10) . Stimulation of EREG by PGE2 is also mediated by PTGER2 and cAMP; however, unlike FGF2, EREG was shown to be PKA dependent, as depicted in Fig. 10 . It was previously shown that LH stimulates FGF2 in vivo and in vitro (28, 37) . FGF2 protein at this stage was mainly localized to luteinizing granulosa cells in the early CL (27) . Here, we report that PGE2 also induces FGF2 in granulosa cells. Three independent lines of evidence support this statement:
(1) the time-dependent induction of FGF2 at the mRNA and protein levels by PGE2; (2) low endogenous PGE2 levels, in PTGS2-silenced cells, exhibited reduced FGF2 (mRNA and protein); and (3) elevation of viable granulosa cells by PGE2 was abolished with FGF2 receptor1 inhibitor, suggesting that FGF2 mediates the effect of PGE2 on granulosa cell viability. Involvement of FGF2 in PGE2 actions was also shown in aortic endothelial cells, where PGE2 effects on proliferation and migration were impaired by FGF2 knockout or FGF receptor1 blockade (45, 46) . FGF2 induced by PGE2 can serve multiple tasks in the ovulating follicle and early CL. It can promote proliferation and survival of granulosa cells [as shown in this study and also by others (44, 47, 48) ]. FGF2 is also a potent inducer of luteal endothelial cell proliferation (28, 29, 49) ; in fact, FGF2 was more potent than vascular endothelial growth factor A for the formation of bovine luteal endothelial networks (49) . Furthermore, in luteal endothelial cells, FGF2 counteracted the proapoptotic and antiangiogenic actions of thrombospondin-1 and transcriptionally repressed THBS1 (29, 37 ). These studies demonstrate that FGF2 supports both granulosa and endothelial cell survival.
Specific receptor agonist experiments carried out here showed that PGE2 promotes FGF2 and EREG expression in granulosa cells primarily through PTGER2. Nevertheless, these experiments also demonstrated that PGE2 can act via PTGER1 and PTGER4. It is conceivable, therefore, that a selective agonist such as PTGER2 would be less potent than PGE2 in binding to its other subtypes. The same phenomenon was observed in other reports (50, 51) .
In preparation for ovulation, LH also induces EGFlike peptides in granulosa cells; these peptides include AREG, EREG, and betacellulin, each encoded by separate genes (52) . These factors mediated LH actions in granulosa and cumulus cells by promoting cumulus expansion and oocyte maturation (53) (54) (55) (56) duration of elevated FGF2 and EGF-like factors, thus supporting the various actions of these hormones on granulosa cell survival, cumulus expansion, and follicular rupture during the periovulatory period. cAMP is a well-known second messenger of PGE2 acting via PTGER2 and PTGER4 (15, 20) . As confirmed here, PGE2 and PTGER2 agonist elevate cAMP in bovine granulosa cells. Forskolin also elevates cAMP levels because it directly activates adenylyl cyclase. Therefore, FGF2 and EREG stimulated by PGE2, PTGER2 agonist, and forskolin are expected to use cAMP-sensitive effectors: PKA or EPAC. We found that FGF2 was not affected by the presence of H89 (a PKA inhibitor); on the other hand, it was affected by EPAC manipulation: FGF2 was stimulated by the EPAC selective activator 8pCPT-AM, and inhibited by RAPGEF3 knockdown. These findings indicate that PGE2 uses EPAC1 as a preferred cAMP effector pathway to stimulate FGF2. PGE2 signaling that favors the EPAC pathway was also demonstrated in rat microglia and macrophages (50, 51, 60).
Using bovine granulosa cells, we showed that EREG expression is regulated in a PKA-dependent manner. cAMP generated by either PTGER2 agonist, PGE2, or forskolin elevated EREG levels. In contrast to FGF2, the action of these upstream stimulants was greatly reduced in the presence of H89, suggesting PKA-dependence of EREG. Similarly, in human granulosa cells, PGE2-stimulated AREG and EREG expression was suppressed by the presence of H89 (34) . These findings are also in agreement with previous findings showing that EREG induction in murine granulosa cells was reported to be regulated by Sp1, a transcriptional factor that can be phosphorylated by PKA (61, 62) . Also AREG was shown to be regulated by PKA phosphorylating CREB in murine granulosa cells (63, 64) . However, EREG was also found in this study to be induced by EPAC activator 8pCPT-AM. However, there were noteworthy differences between FGF2 and EREG: Whereas EREG response to upstream stimulants (PGE2, PTGER2, or forskolin) was markedly higher than that of FGF2, its induction by 8pCPT-AM was at a magnitude similar to FGF2. Furthermore, the effective knockdown of RAPGEF3 or RAPGEF4 did not reduce the expression of EREG. The distinct decrease of FGF2 when RAPGEF3 was knockdown reinforces the conclusion that FGF2 is dependent on EPAC1 activation by cAMP. The reason why EPAC Figure 9 . Effect of RAPGEFs (EPACs) silencing on (A) FGF2 and (B) EREG mRNA levels. Bovine granulosa cells were transfected either with scrambled siRNA (designated as 1) or RAPGEF3 siRNA (EPAC1) or RAPGEF4 siRNA (EPAC2). At 42 h after transfection, the media were changed and forskolin (1 mmol/L) was added for 6 h. RNA was extracted at 48 h after transfection. The results represent the mean 6 SEM from five independent experiments. P values indicate significant differences from scrambled siRNA without forskolin. Figure 10 . Schematic illustration demonstrating autocrine actions and downstream signaling of PGE2 in bovine granulosa cells. PTSG2, the rate-limiting enzyme in PGE2 production, is localized to nuclear membrane. PGE2 binds PTGER2 coupled to GaS protein, leading to activation of adenylyl cyclase. Activated adenylyl cyclase, either by PTGER2 or directly by forskolin, elevates cAMP production. Elevated cAMP levels trigger the two downstream signaling pathways: PKA and EPAC. Inhibition of PKA by H89 only downregulates EREG. EPAC activation by 8pCPT-AM stimulates FGF2 and EREG; however, silencing RAPGEF3 (EPAC1) only reduced FGF2 but not EREG. These studies show that PGE2 acting via PTGER2 induces FGF2 in an EPAC-dependent manner, whereas EREG also stimulated by PTGER2 is mediated by PKA.
activator elevates EREG is unclear at present; perhaps owing to its strong PKA dependence, a residual activation of PKA by this cAMP analog may have caused this response. Nevertheless, this issue requires further research.
The results of the current study extend our knowledge of the roles and signaling pathways used by PGE2 and its PTGER2 during the periovulatory period. By increasing EREG, PGE2 acts to promote cumulus expansion, oocyte meiotic resumption, and further elevation of PGE2 synthesis. By stimulating FGF2, PGE2 can act to maintain granulosa cell proliferation and survival during follicular-luteal transition. FGF2 from granulosa cells could also affect endothelial cells and promote their proliferation and migration during this period. Furthermore, our findings highlight the signal transduction mechanisms used by PTGER2 using specific cAMP effectors: PKA for EREG and EPAC1 for FGF2.
